LOS ALTOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 3:45 p.m. ET. A link to the live and archived webcast may be accessed on the Unicycive website under the Investors section: Events and Presentations. About Unicycive Therapeutics Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA)...

MIDLAND, Texas, April 09, 2026 (GLOBE NEWSWIRE) — New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI) today announced the pricing of its previously announced underwritten public offering of 29,850,746 shares of its common stock, par value $0.0001 per share (“Common Stock”), at a price to the public of $3.35 per share, resulting in gross proceeds to the Company of approximately $100 million, before deducting the underwriters’ discount and commissions and estimated offering fees and expenses, pursuant to an effective shelf registration statement on Form S-3 (the “Registration Statement”) filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company intends to use the net proceeds it receives from the offering to repay all outstanding borrowings under a senior secured convertible promissory...

RICHMOND, Va., April 09, 2026 (GLOBE NEWSWIRE) — Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT. Access to the Live Webcast Presentation: The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the event begins. Live webcast link: https://edge.media-server.com/mmc/p/3k7nbxjp Participants may access the presentation telephonically by registering with the following link: https://register-conf.media-server.com/register/BIea9b995134de41e68f49a057c2a6cb66 (Registrants...

SAINT HELIER, Jersey — April 7, 2026 — CoinShares PLC (“CoinShares” or “the Group”) (Nasdaq: CSHR), a leading global asset manager specializing in digital assets, today announced that Jean-Marie Mognetti, President, Chief Executive Officer and Co-Founder, will participate in the Centri Capital Conference 2026 on 14 April 2026 at 11:30 AM ET. CoinShares is the world’s fourth-largest digital asset ETP manager and holds the #1 position in Europe with approximately 34% market share. The Company has been at the forefront of regulated digital asset investment since launching the world’s first Bitcoin ETP in 2015. Event Details:Event: Centri Capital Conference 2026 Date: 14 April 2026 Time: 11:30 AM ET Format: Fireside chatAbout CoinShares PLC CoinShares PLC (Nasdaq: CSHR) is a leading global asset manager...

DENVER, April 09, 2026 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen and twenty-six weeks ended February 28, 2026. Second Quarter Summary:(1)Net sales of $326.0 million versus $359.7 million Net loss of $159.7 million versus net income of $36.7 million Loss per diluted share of $1.73 versus earnings per diluted share of $0.36 Adjusted Diluted EPS(2) of $0.45 versus $0.46 Adjusted EBITDA(3) of $55.5 million versus $68.0 millionUpdating Fiscal Year 2026(4) Outlook:Net sales expected to range between $1.31 and $1.35 billion, or -10% to -7% year-over-year Gross margins expected to decline between 300 and 350 basis points year-over-year Adjusted EBITDA expected to range between...

ENGLEWOOD CLIFFS, N.J., April 09, 2026 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today announced that it plans to release results for the first quarter ended March 31, 2026, before the market opens on Thursday, April 23, 2026. Management will also host a conference call and audio webcast at 10:00 a.m. ET on April 23, 2026, to review the Company’s financial performance and operating results. Chairman and Chief Executive Officer Frank Sorrentino III and Senior Executive Vice President and Chief Financial Officer William S. Burns will host the call. The conference call dial-in number is 1 (646) 307-1963, access code 8368502. Please dial in at least five minutes before the start of the call to register. An audio webcast of the conference...

Ajit Kara joins GXO as Senior Vice President of Account ManagementKara will lead the Account Management organization with responsibility for enabling scalable growth, value creation and strengthening long-term partnerships.Industry veteran Ajit Kara joins GXO as Senior Vice President of Account Management GREENWICH, Conn., April 09, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure‑play contract logistics provider, announced today that Ajit Kara has joined GXO as Senior Vice President, Account Management, reporting to Chief Commercial Officer Karen Bomber. In this newly created role, Kara will lead the Account Management organization with responsibility for enabling scalable growth, value creation and strengthening long-term partnerships. He will be based at GXO’s headquarters in Greenwich,...

New preclinical data for FHD-909 (LY4050784) reinforcing the potential for expansion opportunities in combination with an anti-PD-1 antibody in SMARCA4 (BRG1)-mutant lung cancer Preclinical characterization of FHT-171, a selective CBP degrader with promise in ER+ breast cancer Progress across Selective EP300 degrader in hematological malignancies and Selective ARID1B degrader in ARID1A-mutant tumors WATERTOWN, Mass., April 09, 2026 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that it will have multiple oral and poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting being held April 17-22, 2026, in San Diego, California....

PORTLAND, Tenn., April 09, 2026 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2026 results before market open on Tuesday, May 5, 2026, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day. Interested investors and other parties can access the live webcast through the Investor Relations section of the Company’s website at https://investors.shoals.com. An archived replay of the webcast will be available shortly after the event concludes. About Shoals Technologies Group, Inc.Shoals Technologies Group is a leading manufacturer of advanced electrical infrastructure solutions for mission‑critical applications across utility‑scale solar, battery storage, and data center power systems. Since its founding in...

Sale to Vireo Growth enhances focus on North American consumer lawn and garden business MARYSVILLE, Ohio, April 09, 2026 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that it has completed the sale of its subsidiary The Hawthorne Gardening Company to Vireo Growth, Inc. Hawthorne was acquired by Vireo Growth (CSE: VREO; OTCQX: VREOF) in exchange for Vireo shares that are being held by an independent strategic partner and will be reported in the Company’s financial statements among its other investments. The Company also reaffirmed its fiscal 2026 guidance, as the divestiture does not impact the full-year outlook. “The divestiture of Hawthorne demonstrates further progress toward our strategy to drive long-term growth...